Cargando…

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting

Background: For patients with schizophrenia, the transition from inpatient hospitalization to outpatient care presents a challenge to providing continuous care. Lapses in care during this time period can result in poor clinical outcomes. To date, there is little information regarding the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farr, Amanda M., Smith, David M., Pesa, Jacqueline A., Cao, Zhun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2014
Materias:	Neurological Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471406/ https://www.ncbi.nlm.nih.gov/pubmed/37664086 http://dx.doi.org/10.36469/9882

Ejemplares similares

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
por: Frois, Christian, et al.
Publicado: (2013)

Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia
por: Kozma, Chris, et al.
Publicado: (2016)

Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
por: Pesa, Jacqueline A., et al.
Publicado: (2015)

Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
por: Bhatta, Madhav P., et al.
Publicado: (2021)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
por: Xie, Lin, et al.
Publicado: (2013)

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients
por: Kamat, Siddhesh A, et al.
Publicado: (2015)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia
por: Noordsy, Douglas L, et al.
Publicado: (2010)

PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia
por: Pesa, J., et al.
Publicado: (2021)

Metabolic syndrome and 10-year risk of cardiovascular events among schizophrenia inpatients treated with antipsychotics
por: Naderyan Fe'li, Shadi, et al.
Publicado: (2019)

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2018)

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
por: Lin, Dee, et al.
Publicado: (2023)

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings
por: Barclay, Krista, et al.
Publicado: (2019)

Use of Conventional Antipsychotics and the Cost of Treating Schizophrenia
por: Lyu, Ramon R., et al.
Publicado: (2001)

Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia
por: El Khoury, Antoine C., et al.
Publicado: (2020)

Stewardship applied to antipsychotics: Development of an antipsychotic stewardship program in inpatient settings for monitoring and optimizing outcomes
por: Gonzales, Gillian, et al.
Publicado: (2022)

Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia
por: Panish, Jessica, et al.
Publicado: (2013)

Auditory and Visual Hallucinations Associated With Nitrofurantoin Use in an Inpatient Setting: A Case Report
por: Gilman, Alex, et al.
Publicado: (2023)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari, Sulaiman, et al.
Publicado: (2015)

A Case of Refractory Delirium Managed by a Multimodal Approach Using Atypical Antipsychotics, Antidepressants, and Benzodiazepines in an ICU Setting
por: Vadagandla, Koteshwareddy, et al.
Publicado: (2022)

Assessment of oral overlap with antipsychotic long-acting injectables initiated in an inpatient setting
por: Tran, Jennifer T., et al.
Publicado: (2023)

Case Selection for a Medicaid Chronic Care Management Program
por: Weir, Sharada, et al.
Publicado: (2008)

The relationship between combined antipsychotic use and clinical features in schizophrenia spectrum patients treated in inpatient ward: A retrospective study
por: Baklaci, U.
Publicado: (2021)

Executive Dysfunction among Children with Antipsychotic Treated Schizophrenia
por: Wiguna, Tjhin, et al.
Publicado: (2014)

Structural Equation Model (SEM) of Stroke Mortality in Spanish Inpatient Hospital Settings: The Role of Individual and Contextual Factors
por: de la Fuente, Jesús, et al.
Publicado: (2019)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Prescribing and Monitoring of High Dose Antipsychotic Therapy (HDAT) in the Acute Inpatient Setting
por: Buston, Gemma, et al.
Publicado: (2022)

Prevalence and Correlates of Cigarette Smoking among Chinese Schizophrenia Inpatients Receiving Antipsychotic Mono-Therapy
por: Xu, Yan-Min, et al.
Publicado: (2014)

Five-Years Angiographic Follow-Up of Wide-Neck Intracranial Aneurysms Treated With LEO Plus Stent
por: Pumar, José M., et al.
Publicado: (2021)

Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up
por: Kaufmann, Maxi, et al.
Publicado: (2018)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Liu-Seifert, Hong, et al.
Publicado: (2009)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medications
por: Jaberi, Nayyer, et al.
Publicado: (2020)

Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review
por: Saber, Wael K, et al.
Publicado: (2022)

Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report
por: Solanki, Siddhant, et al.
Publicado: (2023)

High-Resolution MR for Follow-Up of Intracranial Steno-Occlusive Disease Treated by Endovascular Treatment
por: Wang, Junjie, et al.
Publicado: (2021)

Prolactin response to antipsychotics: An inpatient study
por: Dehelean, Liana, et al.
Publicado: (2020)

Inpatient rehabilitation service utilization and outcomes under US ACA Medicaid expansion
por: Cao, Ying ( Jessica), et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hdbrflnel04t8g9j5gmn0env9o